End-of-day quote
Shanghai S.E.
06:00:00 2024-05-09 pm EDT
|
5-day change
|
1st Jan Change
|
4.68
CNY
|
-1.06%
|
|
+4.23%
|
-19.86%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
1,991
|
2,514
|
2,607
|
2,998
|
2,888
|
3,212
|
Enterprise Value (EV)
1 |
2,186
|
1,776
|
1,763
|
1,607
|
1,523
|
1,816
|
P/E ratio
|
91.6
x
|
-46.7
x
|
44.9
x
|
347
x
|
-74.8
x
|
141
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
0.51%
|
Capitalization / Revenue
|
1.6
x
|
2.98
x
|
3.8
x
|
4.18
x
|
4.31
x
|
3.23
x
|
EV / Revenue
|
1.76
x
|
2.11
x
|
2.57
x
|
2.24
x
|
2.28
x
|
1.82
x
|
EV / EBITDA
|
70.8
x
|
20.4
x
|
433
x
|
1,431
x
|
-50.7
x
|
-135
x
|
EV / FCF
|
-80.8
x
|
-5.4
x
|
406
x
|
3.02
x
|
-108
x
|
-182
x
|
FCF Yield
|
-1.24%
|
-18.5%
|
0.25%
|
33.1%
|
-0.92%
|
-0.55%
|
Price to Book
|
1.11
x
|
1.22
x
|
1.23
x
|
1.4
x
|
1.38
x
|
1.52
x
|
Nbr of stocks (in thousands)
|
550,000
|
550,000
|
550,000
|
550,000
|
550,000
|
550,000
|
Reference price
2 |
3.620
|
4.570
|
4.740
|
5.450
|
5.250
|
5.840
|
Announcement Date
|
4/18/19
|
4/16/20
|
3/30/21
|
3/30/22
|
3/30/23
|
3/28/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
1,245
|
843.8
|
685.4
|
717.5
|
669.2
|
995.1
|
EBITDA
1 |
30.86
|
86.86
|
4.072
|
1.123
|
-30.02
|
-13.47
|
EBIT
1 |
-47.72
|
4.567
|
-25.05
|
-28.64
|
-60.16
|
-38.45
|
Operating Margin
|
-3.83%
|
0.54%
|
-3.65%
|
-3.99%
|
-8.99%
|
-3.86%
|
Earnings before Tax (EBT)
1 |
15.87
|
84.68
|
71.29
|
5.925
|
-50.58
|
30.29
|
Net income
1 |
21.72
|
-53.81
|
58.01
|
8.658
|
-38.59
|
22.81
|
Net margin
|
1.74%
|
-6.38%
|
8.46%
|
1.21%
|
-5.77%
|
2.29%
|
EPS
2 |
0.0395
|
-0.0978
|
0.1055
|
0.0157
|
-0.0702
|
0.0415
|
Free Cash Flow
1 |
-27.05
|
-329
|
4.341
|
532.2
|
-14.09
|
-9.978
|
FCF margin
|
-2.17%
|
-38.99%
|
0.63%
|
74.17%
|
-2.11%
|
-1%
|
FCF Conversion (EBITDA)
|
-
|
-
|
106.62%
|
47,390.8%
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
7.48%
|
6,146.97%
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
0.0300
|
Announcement Date
|
4/18/19
|
4/16/20
|
3/30/21
|
3/30/22
|
3/30/23
|
3/28/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
195
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
737
|
844
|
1,391
|
1,364
|
1,396
|
Leverage (Debt/EBITDA)
|
6.309
x
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-27
|
-329
|
4.34
|
532
|
-14.1
|
-9.98
|
ROE (net income / shareholders' equity)
|
0.46%
|
2.11%
|
2.78%
|
0.44%
|
-1.83%
|
1.17%
|
ROA (Net income/ Total Assets)
|
-1.14%
|
0.11%
|
-0.6%
|
-0.7%
|
-1.5%
|
-0.94%
|
Assets
1 |
-1,907
|
-49,272
|
-9,726
|
-1,229
|
2,566
|
-2,420
|
Book Value Per Share
2 |
3.270
|
3.760
|
3.870
|
3.880
|
3.810
|
3.850
|
Cash Flow per Share
2 |
0.2000
|
1.320
|
1.120
|
2.230
|
2.200
|
2.320
|
Capex
1 |
43.3
|
32.1
|
21.5
|
26.2
|
22.1
|
26.6
|
Capex / Sales
|
3.47%
|
3.8%
|
3.14%
|
3.65%
|
3.3%
|
2.67%
|
Announcement Date
|
4/18/19
|
4/16/20
|
3/30/21
|
3/30/22
|
3/30/23
|
3/28/24
|
|
1st Jan change
|
Capi.
|
---|
| -19.86% | 356M | | +12.48% | 46.02B | | -1.51% | 18.94B | | -0.52% | 4.25B | | +6.93% | 2.65B | | -12.50% | 1.59B | | +47.10% | 1.33B | | +15.85% | 947M | | +21.37% | 807M | | +26.18% | 440M |
Sanitary Products
|